These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25524139)

  • 21. Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA.
    Dipasquale O; Selvaggi P; Veronese M; Gabay AS; Turkheimer F; Mehta MA
    Neuroimage; 2019 Jul; 195():252-260. PubMed ID: 30953835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users.
    Fagundo AB; Cuyàs E; Verdejo-Garcia A; Khymenets O; Langohr K; Martín-Santos R; Farré M; de la Torre R
    J Psychopharmacol; 2010 Sep; 24(9):1381-93. PubMed ID: 20080926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days.
    Kirilly E; Molnar E; Balogh B; Kantor S; Hansson SR; Palkovits M; Bagdy G
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):795-809. PubMed ID: 18261250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
    Meyer JS; Piper BJ; Vancollie VE
    Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
    Parrott AC
    J Psychopharmacol; 2005 Jan; 19(1):71-83. PubMed ID: 15671132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of early experience and genotype on serotonin transporter regulation in infant rhesus macaques.
    Kinnally EL; Lyons LA; Abel K; Mendoza S; Capitanio JP
    Genes Brain Behav; 2008 Jun; 7(4):481-6. PubMed ID: 18081711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells.
    Popova D; Forsblad A; Hashemian S; Jacobsson SO
    PLoS One; 2016; 11(11):e0166750. PubMed ID: 27861613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.
    Curran HV; Travill RA
    Addiction; 1997 Jul; 92(7):821-31. PubMed ID: 9293041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
    Liechti ME; Saur MR; Gamma A; Hell D; Vollenweider FX
    Neuropsychopharmacology; 2000 Oct; 23(4):396-404. PubMed ID: 10989266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users.
    Roiser JP; Cook LJ; Cooper JD; Rubinsztein DC; Sahakian BJ
    Am J Psychiatry; 2005 Mar; 162(3):609-12. PubMed ID: 15741482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
    Hysek CM; Simmler LD; Schillinger N; Meyer N; Schmid Y; Donzelli M; Grouzmann E; Liechti ME
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):371-81. PubMed ID: 24103254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users.
    Croft RJ; Klugman A; Baldeweg T; Gruzelier JH
    Am J Psychiatry; 2001 Oct; 158(10):1687-92. PubMed ID: 11579003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.
    Price LH; Ricaurte GA; Krystal JH; Heninger GR
    Arch Gen Psychiatry; 1989 Jan; 46(1):20-2. PubMed ID: 2562914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
    J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors.
    van Wel JH; Kuypers KP; Theunissen EL; Bosker WM; Bakker K; Ramaekers JG
    PLoS One; 2012; 7(7):e40187. PubMed ID: 22808116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effect of the 5-HTT gene-linked polymorphic region on emotional eating during stress exposure following tryptophan challenge.
    Markus CR; Verschoor E; Smeets T
    J Nutr Biochem; 2012 Apr; 23(4):410-6. PubMed ID: 21658929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
    Morgan MJ
    Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.